Titan’s Single Port Orifice Robotic Technology (SPORT™) Surgical System, currently under development, comprises a surgeon-controlled single incision platform. The platform includes a 3D vision system and interactive instruments for performing MIS procedures.
The surgeon workstation provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and for providing a 3D endoscopic view inside a patient’s body during MIS procedures.
The single incision platform is being developed with the goal of providing interactive instruments and a 3D vision system capable of being inserted into the patient’s body cavity through a single incision.
The design contemplates a collapsible device that, when collapsed, would be capable of being inserted into the patient’s body cavity through a skin incision of approximately 25mm.
Once inserted, the device is configured to deploy into a working configuration whereby the 3D vision system and interactive instruments would be capable of being controlled by a surgeon at the workstation.
The robotic surgical system is being developed with the objective of delivering multiple benefits to patients, surgeons and hospitals. They include the following:
For the Patient:
- A shorter hospital stay
- Reduced pain, scarring and risk of infection
- Less blood loss
- Quicker recovery
For the Surgeon:
- Enhanced functionality, dexterity, versatility, field of vision via 3D technology and precision.
- Improved ergonomics which potentially extend surgeons’ operating careers.
For the Hospital:
- Decreased length of patient stay and reduced risk of infection improves patient throughput leading to improved return on assets.
- Reduced risk of infection also contributes to improved margins on case rate procedures.
- Increased patient satisfaction, which contributes to patient referrals and patient demand.
- Increased physician satisfaction, which impacts physician demand for hospital usage in both robotic and non-robotic cases.
The Company currently has 7 granted patents and 11 patent applications filed in the U.S. or under the Patent Cooperation Treaty.